Stepan | SCL - Sales Revenues

Stepan reported $532.13M in Sales Revenues for its fiscal quarter ending in December of 2023.

Sales Change Date
Akzo Nobel EUR 2.64B 111M Mar/2024
Albemarle USD 2.36B 45.4M Dec/2023
Arkema EUR 2.23B 99M Dec/2023
Ashland USD 473M 44M Dec/2023
Avient USD 719M 34.7M Dec/2023
Balchem USD 228.7M 1.25M Dec/2023
BASF EUR 15.87B 136M Dec/2023
Covestro EUR 3.35B 222M Dec/2023
Croda International GBP 813.6M 67.3M Dec/2023
Ecolab USD 3.94B 19.7M Dec/2023
Entegris USD 812.29M 75.95M Dec/2023
Evogene USD 578K 3.19M Dec/2023
HB Fuller USD 810.42M 92.46M Dec/2023
Huntsman USD 1.4B 103M Dec/2023
Innospec USD 494.7M 30.6M Dec/2023
International Flavors Fragrances USD 2.7B 117M Dec/2023
Minerals Technologies USD 534.5M 10M Mar/2024
NewMarket USD 697K 666.45M Mar/2024
Olin USD 1.63B 15.4M Mar/2024
Quaker Chemical USD 467.11M 23.5M Dec/2023
Rayonier Advanced Materials USD 422.49M 53.82M Dec/2023
Sensient Technologies USD 349.3M 14.53M Dec/2023
Solvay EUR 1.34B 1.69B Dec/2023
Stepan USD 532.13M 30.1M Dec/2023
Valhi USD 453M 15.9M Dec/2023